Role of cytokines in neurological disorders
- PMID: 12871095
- DOI: 10.2174/0929867033456918
Role of cytokines in neurological disorders
Abstract
The balance between cytokines with pro- and anti-inflammatory effects contributes to the course of the Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. TNFalpha seems to be an important factor in the cascade of events leading to demyelination and even axonal damage. During the acute phase, the serum concentrations of TNFalpha and IL-6 are elevated while anti-inflammatory cytokines are up-regulated in the recovery phase. Cytokines also have a key role in the pathogenesis of multiple sclerosis and most data suggest that this effect is mediated by myelin-specific CD4 T lymphocytes secreting Th type 1 cytokines. However, several different immune cells including B lymphocytes, CD8 T lymphocytes and NK T lymphocytes are also involved in the pathogenesis. Both Th1 and Th2 lymphocytes and cytokines probably participate in the development of myasthenia gravis (MG). The IFNalpha production is probably related to the severity of the disease, with clinical improvement associated with decreased production. The serum levels of IL-18 are significantly elevated in MG, with highest concentrations in patients with generalized disease. The immune system may be involved in the pathogenesis of AD by the effect of microglia, which can induce microglial activation with subsequent release of pro-inflammatory cytokines. In parkinsonism, there is evidence of chronic inflammation in the substantia nigra and striatum. Activated microglia, producing proinflammatory cytokines, surround the degenerating dopaminergic neurons and may contribute to the dopaminergic neuron loss. Studies of patients with epilepsy and animals with experimentally induced seizures indicate that cytokines may also influence the electrophysiological properties of neurons.
Similar articles
-
Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.Acta Neurol Scand Suppl. 1994;158:1-58. Acta Neurol Scand Suppl. 1994. PMID: 7732782
-
T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1431-9. doi: 10.1136/jnnp.2004.052282. J Neurol Neurosurg Psychiatry. 2005. PMID: 16170091 Free PMC article.
-
[Neuroimmunological diseases: update].Nihon Rinsho. 2013 May;71(5):771-7. Nihon Rinsho. 2013. PMID: 23777080 Review. Japanese.
-
[Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].Rev Neurol (Paris). 2002 Mar;158(3):301-10. Rev Neurol (Paris). 2002. PMID: 11976589 Review. French.
-
Neuronal injury in chronic CNS inflammation.Best Pract Res Clin Anaesthesiol. 2010 Dec;24(4):551-62. doi: 10.1016/j.bpa.2010.11.001. Epub 2010 Nov 29. Best Pract Res Clin Anaesthesiol. 2010. PMID: 21619866 Review.
Cited by
-
Caspase signalling controls microglia activation and neurotoxicity.Nature. 2011 Apr 21;472(7343):319-24. doi: 10.1038/nature09788. Epub 2011 Mar 9. Nature. 2011. PMID: 21389984
-
Administration of Myelin Basic Protein Peptides Encapsulated in Mannosylated Liposomes Normalizes Level of Serum TNF-α and IL-2 and Chemoattractants CCL2 and CCL4 in Multiple Sclerosis Patients.Mediators Inflamm. 2016;2016:2847232. doi: 10.1155/2016/2847232. Epub 2016 Apr 28. Mediators Inflamm. 2016. PMID: 27239100 Free PMC article. Clinical Trial.
-
Dendritic and Langerhans cells respond to Aβ peptides differently: implication for AD immunotherapy.Oncotarget. 2015 Nov 3;6(34):35443-57. doi: 10.18632/oncotarget.6123. Oncotarget. 2015. PMID: 26473448 Free PMC article.
-
Global Gene Expression Profiling and Transcription Factor Network Analysis of Cognitive Aging in Monozygotic Twins.Front Genet. 2021 Jun 14;12:675587. doi: 10.3389/fgene.2021.675587. eCollection 2021. Front Genet. 2021. PMID: 34194475 Free PMC article.
-
Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression.Dialogues Clin Neurosci. 2007;9(2):125-39. doi: 10.31887/DCNS.2007.9.2/mpucak. Dialogues Clin Neurosci. 2007. PMID: 17726912 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
